Categories

Volume 4 Issue 1 (January - February, 2016)

Original Articles

A comparative study of olopatadine and bepotastine in cases of allergic conjunctivitis
Garima Agarwal

Background: Ocular allergy is a commonly encountered pathology in clinical practice, with an increase in number of patients noticed in the last decade. The present study compared olopatadine and bepotastine in cases of allergic conjunctivitis. Materials & Methods: The present study was conducted on 68 patients of allergic conjunctivitis of both genders. Patients were divided into 2 groups. Group I were given topical 0.1% Olopatadine eyedrops BD and group II were given topical 1.5% Bepotastine eyedrops BD. Ocular redness and discharge were scored using 5-point scale (0–4), where 0 indicated no redness or no discharge and 4 indicated severe redness or copious discharge. Results: Out of 68 patients, males were 36 and females were 32. The mean itch score of group I at presentation was 2.3, in group II was 2.1, after 1 day was 1.4 and 1.3 in group I and group II respectively and at 1 week was 0.6 and 0.7 in group I and group II respectively. Redness was seen in 12 in group I and 10 in group II, discharge seen in 16 in group I and 15 in group II, foreign body sensation 20 in group I and 17 in group II and watering in 16 in group I and 18 in group II. The difference was non- significant (P> 0.05). Conclusion: Authors found that both Olopatadine and Bepotastine eyedrops are effective in cases of allergic conjunctivitis. Key words: Allergic conjunctivitis, Bepotastine, Olopatadine

 
Abstract View | Download PDF | Current Issue